; Dr. Reddy's Laboratories Limited – Product Pipeline Review – Q1 2011
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Dr. Reddy's Laboratories Limited – Product Pipeline Review – Q1 2011

VIEWS: 13 PAGES: 88

Dr. Reddy's Laboratories Limited – Product Pipeline Review – Q1 2011 Summary Global Market Direct’s pharmaceuticals report, “Dr. Reddy's Laboratories Limited - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team. Scope - Dr. Reddy's Laboratories Limited - Brief company overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Dr. Reddy's Laboratories Limited human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Dr. Reddy's Laboratories Limited with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Dr. Reddy's Laboratories Limited’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products. Reasons to buy - Evaluate Dr. Reddy's Laboratories Limited’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Dr. Reddy's Laboratories Limited in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Dr. Reddy's Laboratories Limited’s R&D portfolio and develop key s

More Info
  • pg 1
									    Dr. Reddy's Laboratories Limited – Product Pipeline
                    Review – Q1 2011
                                                                                          Reference Code: GMDHC1185CDB

                                                                                                Publication Date: MAY 2011




Dr. Reddy's Laboratories Limited – Product Pipeline Review – Q1 2011                        GMDHC1185CDB / Published MAY 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                Page(1)
Dr. Reddy's Laboratories Limited – Product Pipeline Review




Ta b le o f Co n te n t
Table of Content                                                                                                      2
List of Tables                                                                                                        5
List of Figures                                                                                                       5
Dr. Reddy's Laboratories Limited Snapshot                                                                             6
    Dr. Reddy's Laboratories Limited Overview                                                                         6
    Key Information                                                                                                   6
    Key Facts                                                                                                         6
Dr. Reddy's Laboratories Limited – Research and Development Overview                                                  7
    Key Therapeutic Areas                                                                                             7
Dr. Reddy's Laboratories Limited – Pipeline Review                                                                   10
    Pipeline Products by Stage of Development                                                                        10
    Pipeline Products – Monotherapy                                                                                  11
Dr. Reddy's Laboratories Limited – Pipeline Products Glance                                                          12
    Dr. Reddy's Laboratories Limited Clinical Stage Pipeline Products                                                12
         Phase II Products/Combination Treatment Modalities                                                          12
         Phase I Products/Combination Treatment Modalities                                                           13
    Dr. Reddy's Laboratories Limited–Early Stage Pipeline Products                                                   14
         Pre-Clinical Products/Combination Treatment Modalities                                                      14
Dr. Reddy's Laboratories Limited – Drug Profiles                                                                     15
    DRF 10945                                                                                                        15
         Product Description                                                                                         15
         Mechanism of Action                                                                                         15
         R&D Progress                                                                                                15
    DRL 11605                                                                                                        16
         Product Description                                                                                         16
         Mechanism of Action                                                                                         16
         R&D Progress                                                                                                16
    DRL 16536                                                                                                        17
         Product Description                                                                                         17
         Mechanism of Action                                                                                         17
         R&D Progress                                                                                                17
    DRL 17822                                                                                                        18
         Product Description                                                                                         18
         Mechanism of Action                                                                                         18
         R&D Progress                                                                                                18
    DRL16536                                                                                                         19
         Product Description                                                                                         19
         Mechanism of Action                                                                                         19
         R&D Progress                                                                                                19
    RUS 3108                                                                                                         20
         Product Description                                                                                         20
         Mechanism of Action                                                                                         20
         R&D Progress                                                                                                20
    ADC3322                                                                                                          21
         Product Description                                                                                         21
         Mechanism of Action                                                                                         21




Dr. Reddy's Laboratories Limited – Product Pipeline Review – Q1 2011                      GMDHC1185CDB / Published MAY 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                             Page(2)
Dr. Reddy's Laboratories Limited – Product Pipeline Review



         R&D Progress                                                                                                            21
    DRL 12424                                                                                                                    22
         Product Description                                                                                                     22
         Mechanism of Action                                                                                                     22
         R&D Progress                                                                                                            22
    DRL 15725                                                                                                                    23
         Product Description                                                                                                     23
         Mechanism of Action                                                                                                     23
         R&D Progress                                                                                                            23
    DRL 16048                                                                                                                    24
         Product Description                                                                                                     24
         Mechanism of Action                                                                                                     24
         R&D Progress                                                                                                            24
    DRL 16805                                                                                                                    25
         Product Description                                                                                                     25
         Mechanism of Action                                                                                                     25
         R&D Progress                                                                                                            25
Dr. Reddy's Laboratories Limited – Pipeline Analysis                                                                             26
    Dr. Reddy's Laboratories Limited – Pipeline Products by Therapeutic Class                                                    26
    Dr. Reddy's Laboratories Limited - Pipeline Products By Target                                                               28
    Dr. Reddy's Laboratories Limited – Pipeline Products by Route of Administration                                              29
    Dr. Reddy's Laboratories Limited – Pipeline Products by Molecule Type                                                        30
Dr. Reddy's Laboratories Limited - Dormant Projects                                                                              31
Dr. Reddy's Laboratories Limited - Discontinued Pipeline Products                                                                32
    Discontinued Pipeline Product Profiles                                                                                       32
         DRL 11605                                                                                                               32
         DRL 12424                                                                                                               32
Dr. Reddy's Laboratories Limited – Company Statement                                                                             33
Dr. Reddy's Laboratories Limited – Locations And Subsidiaries                                                                    35
    Head Office                                                                                                                  35
    Other Locations & Subsidiaries                                                                                               35
Financial Deals Landscape                                                                                                        37
    Dr. Reddy's Laboratories Limited, Deals Volume Summary, 2004 to YTD 2011                                                     37
    Dr. Reddy's Laboratories Limited, Deals Summary By Region, 2004 to YTD 2011                                                  38
    Dr. Reddy's Laboratories Limited, Deals Summary, 2004 to YTD 2011                                                            39
    Dr. Reddy's Laboratories Limited Detailed Deal Summary                                                                       42
         Asset Purchase                                                                                                          42
         Dow Chemical Sells Its Dowpharma Small Molecules Business                                                               42
         Dr. Reddy’s Acquires Contract Manufacturing Business From BASF                                                          43
         Reddy Pharma Acquires Assets From Laboratorios Litaphar                                                                 45
         Dr. Reddy's Laboratories Acquires Three Off-Patent Products From PDL Biopharma                                          46
         Watson Pharmaceuticals Acquires Solid Dosage Manufacturing Facility From Dr. Reddy's Laboratories                       48
         Dr. Reddy’s Laboratories Acquires API Business From Roche                                                               49
         Acquisition                                                                                                             51
         Dr. Reddy's Laboratories Acquires Stake In Perlecan Pharma From Citigroup, ICICI And IDBI                               51
         Dr. Reddy’s Acquires Jet Generici                                                                                       53
         Dr. Reddy's Laboratories Acquires Betapharm Arzneimittel From 3i Group And Clarat Partners                              54
         Dr. Reddy’s Laboratories Acquires Industrias Quimicas Falcon de Mexico From Roche                                       56




Dr. Reddy's Laboratories Limited – Product Pipeline Review – Q1 2011                                  GMDHC1185CDB / Published MAY 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                                         Page(3)
Dr. Reddy's Laboratories Limited – Product Pipeline Review



         Dr. Reddy's Sells Biomed To KT&T                                                                              57
         Dr. Reddy's Laboratories Acquires Trigenesis Therapeutics                                                     58
         Reddy Antilles Acquires Remaining 10.2% Stake In Reddy US Therapeutics                                        59
         Venture Financing                                                                                             60
         Perlecan Pharma Raises $52.5 Million                                                                          60
         Equity Offering                                                                                               62
         Dr. Reddy's Laboratories Completes Public Offering Of $229 Million                                            62
         GlaxoSmithKline Enters Into Co-Marketing Agreement With Dr. Reddy's Laboratories                              64
         Natco Pharma Enters Into Agreement With Dr Reddy's Laboratories                                               65
         Dr. Reddy's Enters Into Co-Marketing Agreement With Schering And Sepracor                                     66
         Antares Pharma Enters Into Agreement With Dr. Reddy's Laboratories                                            68
         Dr. Reddy's Laboratories Enters Into An Agreement With The Medical House                                      69
         Dr. Reddy's Laboratories Signs An Agreement With Albemarle                                                    70
         Dr. Reddy's Laboratories Signs An Agreement With 7TM Pharma                                                   71
         Ceragenix Enters Into Distribution Agreement With Dr. Reddy's                                                 72
         Alchemia Signs An Agreement With Dr Reddy's Laboratories                                                      73
         Dr. Reddy’s Enters Into Agreement With Torrent Pharma                                                         74
         Dr. Reddy's Laboratories Enters Into An Agreement With ClinTec International                                  75
         Dr. Reddy's Laboratories Enters Into An Agreement With Argenta Discovery                                      76
         Merck & Co. Signs An Agreement With Dr. Reddy's Laboratories                                                  77
         Dr. Reddy's Laboratories Enters Into An Agreement With Rheoscience                                            78
         Dr. Reddy's Enters Into Agreement With I-VE
								
To top